Neuropathic pain in burn patients - A common problem with little literature: A systematic review
- PMID: 38472004
- PMCID: PMC11216128
- DOI: 10.1016/j.burns.2024.02.013
Neuropathic pain in burn patients - A common problem with little literature: A systematic review
Abstract
Background: The prevalence of neuropathic pain (NP) in burn patients is reported in the literature to be as high as 80%1. Given the complexity of NP in burn patients and the wide range of treatments available, a systematic review of the literature is warranted to summarize our current understanding of management and treatment of NP in this population.
Methods: This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. The following databases were queried to identify relevant articles: PubMed, Cochrane, Embase, Scopus, Ovid, and Web of Science. The main outcome measures were incidence and management of NP. Secondary outcomes included risk factors for NP.
Results: Included articles presented findings from 11 different countries, capturing outcomes for 4366 patients. Risk factors for neuropathic pain in burn patients were identified, including older age, alcohol and substance abuse, current daily smoking, greater % total body surface area burns (TBSA), and longer hospitalizations. Pharmacologic treatments included gabapentin/pregabalin (n = 7), ascorbic acid (n = 1), and lidocaine (n = 1). Overall, the studies showed varied results regarding the efficacy of pharmacological treatments. While certain studies demonstrated gabapentanoids to be effective in reducing neuropathic symptoms, others found conflicting results. With regards to non-pharmacologic treatments, electroconvulsive therapy (n = 1), electropuncture (n = 1), nerve release/reconstruction (n = 2), and somatosensory feedback rehabilitation (n = 1) were used and demonstrated promise in reducing pain intensity and improving functionality.
Conclusions: Despite NP afflicting the majority of burn patients long after their injury, this systematic review demonstrates insufficient evidence on the pathophysiology, outcomes, and risk factors in NP, as well as the efficacy of various therapies. Future prospective and randomized studies evaluating the etiology of these factors can substantially improve our treatment strategies. This can allow for the development of well-delineated and evidence-based protocols in NP management in hopes of improving quality of life and both psychological and physical function in burn patients.
Keywords: Burns; Itch; Neuropathic pain.
Copyright © 2024 Elsevier Ltd and ISBI. All rights reserved.
Conflict of interest statement
Conflicts of Interest and Disclosures
The authors report no conflicts of interest or financial disclosures related to this manuscript.
Figures
Similar articles
-
Antiepileptic drugs for chronic non-cancer pain in children and adolescents.Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012536. doi: 10.1002/14651858.CD012536.pub2. Cochrane Database Syst Rev. 2017. PMID: 28779491 Free PMC article.
-
Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults.Cochrane Database Syst Rev. 2017 Sep 14;9(9):CD011976. doi: 10.1002/14651858.CD011976.pub2. Cochrane Database Syst Rev. 2017. PMID: 28905362 Free PMC article.
-
Nortriptyline for neuropathic pain in adults.Cochrane Database Syst Rev. 2015 Jan 8;1(1):CD011209. doi: 10.1002/14651858.CD011209.pub2. Cochrane Database Syst Rev. 2015. PMID: 25569864 Free PMC article.
-
Antidepressants for chronic non-cancer pain in children and adolescents.Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012535. doi: 10.1002/14651858.CD012535.pub2. Cochrane Database Syst Rev. 2017. PMID: 28779487 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
Cited by
-
Pathophysiology and management of burn injury-induced pain.Burns Open. 2025 Apr;10:100396. doi: 10.1016/j.burnso.2025.100396. Epub 2025 Feb 19. Burns Open. 2025. PMID: 40255244 Free PMC article.
-
Effectiveness of intravenous lidocaine in treatment of burn pain: a systematic review and meta-analysis of randomzed controlled trials.Ann Med Surg (Lond). 2025 Feb 7;87(3):1628-1636. doi: 10.1097/MS9.0000000000003005. eCollection 2025 Mar. Ann Med Surg (Lond). 2025. PMID: 40213166 Free PMC article.
References
-
- Shu F, Liu H, Lou X, et al. Analysis of the predictors of hypertrophic scarring pain and neuropathic pain after burn. Burns 2022;48(6):1425–34. - PubMed
-
- Gray P, Williams B, Cramond T. Successful use of gabapentin in acute pain management following burn injury: a case series. Pain Med 2008;9(3):371–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous